QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SNN

QT60Smith & Nephew plc
NYSE·Healthcare·Medical - Devices·UK
Latest market price
30.08
+0.01+0.03%
OverviewShort InterestFilings
SNNQT60Smith & Nephew plc·NYSE
OverviewShort InterestFilings
30.08+0.03%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E20.06EPS (ttm)2.40
Insider Own-
Shs Outstand847.65M
Perf Week-1.92%
Market Cap12.51BForward P/E12.20EPS next Y2.46Insider Trans-Shs Float-Perf Month-2.46%
Enterprise Value15.28BPEG0.37EPS next Q0.94Inst Own-Short Float-Perf Quarter-6.99%
Income623.12MP/S1.99EPS this Y-7.72%Inst Trans-Short Ratio-Perf Half Y-6.90%
Sales6.29BP/B2.42EPS next Y11.29%ROA6.10%Short Interest-Perf YTD-8.32%
Book/sh6.24P/C10.00EPS next 5Y9.80%ROE11.79%52W High38.79 -22.45%Perf Year5.06%
Cash/sh0.66P/FCF14.74EPS past 3/5Y42.28% 7.14%ROIC9.11%52W Low28.40 5.92%Perf 3Y-
Dividend Est.0.78 (2.60%)EV/EBITDA9.50Sales past 3/5Y5.81% 6.26%Gross Margin68.01%Volatility1.18% 1.28%Perf 5Y-
Dividend TTM0.78 (2.60%)EV/Sales2.43EPS Y/Y TTM126.51%Oper. Margin16.27%ATR (14)0.57Perf 10Y-
Dividend Ex-DateMar 27, 2026Quick Ratio1.25Sales Y/Y TTM106.35%Profit Margin10.14%RSI (14)44.71Recom2.77
Dividend Gr. 3/5Y0.53% 0.32%Current Ratio2.57EPS Q/Q1097.97%SMA20-0.81%Beta0.49Target Price30.93
Payout52.80%Debt/Eq0.63Sales Q/Q13.36%SMA50-3.32%Rel Volume0.87Prev Close30.07
Employees17,349LT Debt/Eq0.60EarningsAug 04SMA200-10.54%Avg Volume1.20MPrice30.08
IPO DateNov 16, 1999Option/ShortYes / YesEPS/Sales Surpr.1.72% 15.47%Net Debt/EBITDA1.72Volume1,046,788Change0.03%
Analyst Ratings
DateActionAnalystRatingTarget
May-11-26ReiteratedBernsteinMarket Perform$36 → $32
May-11-26ReiteratedCanaccord GenuityHold$32 → $30
Apr-24-26ReiteratedCanaccord GenuityHold$35 → $32
Oct-14-25DowngradeBernsteinOutperform → Market Perform$38
Aug-18-25ReiteratedCanaccord GenuityHold$27 → $36
Mar-12-25DowngradeUBSBuy → Neutral
Nov-04-24ReiteratedCanaccord GenuityBuy$27
Jun-05-24UpgradeUBSNeutral → Buy
Mar-04-22UpgradeRedburn PartnersSell → Neutral
Dec-18-20UpgradeBernsteinMarket Perform → Outperform
Latest News
Jun-11-26
Jun-11-2609:12AM
Smith & Nephew plc (SNN) Shareholder/Analyst Call TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue11,9896,1785,810
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A3,7411,9771,764
Gross Profit8,2484,2024,046
Selling, General and Administrative Excl. Other6,0002,9002,652
Research and Development585297289
Other Operating Expense0-1448
Operating Income1,6621,005657
Interest Expense248156168
Unusual Expense
———
Non-Operating Income (Expense)000
Net Income Before Taxes1,281781498
Income Taxes24115486
Consolidated Net Income1,039626412
Net Income From Continuing Operations1,041626412
Net Income1,039626412
EPS (Recurring)2.421.460.94
EPS (Basic, Before Extraordinaries)2.421.460.94
EPS (Diluted)2.401.440.94
EBITDA2,8161,5801,237
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio12.5322.78—
Price To Sales Ratio1.092.30—
Gross Margin68.8068.0269.64
Operating Margin13.8616.2711.31
Net Margin8.6710.137.09
Shares Outstanding433433438
Market Capitalization13,02514,207—
Operating Lease Expense
———
Insider Trading Volume
$34.76$30.49$26.22$21.96$17.69● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR